摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-溴二氢吲哚 | 86626-38-2

中文名称
4-溴二氢吲哚
中文别名
1H-吲哚,4-溴-2,3-二氢;4-溴-2,3-二氢-1H-吲哚盐酸盐;4-溴吲哚啉
英文名称
4-bromoindoline
英文别名
4-bromo-2,3-dihydro-1H-indole
4-溴二氢吲哚化学式
CAS
86626-38-2
化学式
C8H8BrN
mdl
——
分子量
198.062
InChiKey
YCJCSDSXVHEBRU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    278.8±29.0 °C(Predicted)
  • 密度:
    1.514±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    12
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2933990090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    | 室温 |

SDS

SDS:13c02b222231eae8c7b5924e7e4d6cbd
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Bromoindoline
Synonyms: 4-Bromo-2,3-dihydro-1H-indole

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Bromoindoline
CAS number: 86626-38-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H8BrN
Molecular weight: 198.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-溴二氢吲哚potassium carbonate 、 sodium hydroxide 作用下, 以 四氢呋喃二氯甲烷N,N-二甲基乙酰胺N,N-二甲基甲酰胺丁酮 为溶剂, 反应 42.0h, 生成 (S)-1-(2-methyloxirane-2-carbonyl)indoline-4-carbonitrile
    参考文献:
    名称:
    1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators
    摘要:
    We present a novel series of selective androgen receptor modulators (SARMs) which shows excellent biological activity and physical properties. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)-indoline-4-carbonitriles showed potent binding to the androgen receptor (AR) and activated AR-mediated transcription in vitro. Representative compounds demonstrated diminished activity in promoting the intramolecular interaction between the AR carboxyl (C) and amino (N) termini. This N/C-termini interaction is a biomarker assay for the undesired androgenic responses in vivo. In orchidectomized rats, daily administration of a lead compound from this series showed anabolic activity by increasing levator ani muscle weight. Importantly, minimal androgenic effects (increased tissue weights) were observed in the prostate and seminal vesicles, along with minimal repression of circulating luteinizing hormone (LH) levels and no change in the lipid and triglyceride levels. This lead compound completed a two week rat toxicology study, and was well tolerated at doses up to 100 mg/kg/day, the highest dose tested, for 14 consecutive days.
    DOI:
    10.1021/jm401625b
  • 作为产物:
    描述:
    4-溴吲哚 在 sodium cyanoborohydride 作用下, 以 溶剂黄146 为溶剂, 反应 15.0h, 生成 4-溴二氢吲哚
    参考文献:
    名称:
    铑(III)催化的7位吲哚直接区域选择性合成
    摘要:
    开发了一种有效的,原子经济的一锅法,用于通过铑(III)催化的氧化交叉偶联制备7位取代的吲哚。二氢吲哚衍生物的区域选择性烯烃化,然后一锅法随后的氧化,以良好至优异的产率提供了所需的产物。
    DOI:
    10.1021/ol402626t
点击查看最新优质反应信息

文献信息

  • Ru(<scp>ii</scp>)-Catalyzed C7-acyloxylation of indolines with carboxylic acids
    作者:Pinaki Bhusan De、Sonbidya Banerjee、Sourav Pradhan、Tharmalingam Punniyamurthy
    DOI:10.1039/c8ob01603h
    日期:——

    Ruthenium-catalyzed site-selective C7-acyloxyation of indolines with carboxylic acids is presented that can be oxidized to indoles with diverse functional groups.

    铑催化的选择性C7-酰氧化反应将吲哚与羧酸进行作用,可氧化为具有多种功能基团的吲哚化合物。
  • INDOLE CARBOXAMIDE COMPOUNDS
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:US20160115126A1
    公开(公告)日:2016-04-28
    Disclosed are compounds of Formula (I): or a salt thereof, wherein: X is CR 4 or N; R 1 , R 2 , R 3 , R 4 , and A are defined herein. Also disclosed are methods of using such compounds as inhibitors of Bruton's tyrosine kinase (Btk), and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
    揭示了Formula (I)的化合物: 或其盐,其中:X为CR 4 或N;R 1 ,R 2 ,R 3 ,R 4 和A在此处定义。还揭示了使用这些化合物作为Bruton's酪氨酸激酶(Btk)抑制剂的方法,以及包含这些化合物的药物组合物。这些化合物在治疗、预防或减缓各种治疗领域的疾病或疾病的进展方面非常有用,如自身免疫疾病和血管疾病。
  • 免疫调节化合物、组合物及其应用
    申请人:杭州和正医药有限公司
    公开号:CN112812113B
    公开(公告)日:2022-09-20
    本发明公开了一类结构新颖的酰胺类化合物或其立体异构体或其立体异构体混合物及其药学上可接受的盐,以及在制备治疗从PD1或PD‑L1活性的抑制中获益的疾病、障碍或病症的药物中的应用。本发明化合物表现出很强的PD‑1/PD‑L1阻断活性,同时能够逆转PD‑L1抑制的T细胞功能。同时,本发明化合物能激活PD‑1/PD‑L1结合导致的NFAT信号通路,且可口服吸收,具有良好的药代动力学性质。因此,本发明的化合物可以应用于在单独或与其他药物联合应用治疗从PD1或PD‑L1活性的抑制中获益的疾病、障碍或病症中的应用,包括感染性疾病、免疫性疾病、炎性疾病和癌症。
  • [EN] TRICYCLIC HETEROCYCLIC COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES TRICYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DE LA PHOSPHOINOSITIDE 3-KINASE
    申请人:KARUS THERAPEUTICS LTD
    公开号:WO2017029521A1
    公开(公告)日:2017-02-23
    The invention relates to a compound of formula I: (I) or a pharmaceutically acceptable salt thereof and/or stereoisomers thereof. The compounds of the invention are useful in therapy.
    这项发明涉及到式I的化合物:(I)或其药学上可接受的盐和/或立体异构体。该发明的化合物在治疗中是有用的。
  • DMSO/<i>t</i>-BuONa/O<sub>2</sub>-Mediated Aerobic Dehydrogenation of Saturated <i>N</i>-Heterocycles
    作者:Ruchun Yang、Shusheng Yue、Wei Tan、Yongfa Xie、Hu Cai
    DOI:10.1021/acs.joc.9b03447
    日期:2020.6.5
    Aromatic N-heterocycles such as quinolines, isoquinolines, and indolines are synthesized via sodium tert-butoxide-promoted oxidative dehydrogenation of the saturated heterocycles in DMSO solution. This reaction proceeds under mild reaction conditions and has a good functional group tolerance. Mechanistic studies suggest a radical pathway involving hydrogen abstraction of dimsyl radicals from the N–H
    芳族N-杂环如喹啉,异喹啉和二氢吲哚是通过叔丁醇钠促进的DMSO溶液中饱和杂环的氧化脱氢而合成的。该反应在温和的反应条件下进行并且具有良好的官能团耐受性。机理研究表明,一种自由基途径涉及从底物的N–H键或α–C–H夺取二甲基自由基的氢以及随后氮或α-氨基烷基自由基的氧化。
查看更多

同类化合物

(Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (R)-(+)-5'-苄氧基卡维地洛 (R)-卡洛芬 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (3Z)-3-(1H-咪唑-5-基亚甲基)-5-甲氧基-1H-吲哚-2-酮 (3Z)-3-[[[4-(二甲基氨基)苯基]亚甲基]-1H-吲哚-2-酮 (3R)-(-)-3-(1-甲基吲哚-3-基)丁酸甲酯 (3-氯-4,5-二氢-1,2-恶唑-5-基)(1,3-二氧代-1,3-二氢-2H-异吲哚-2-基)乙酸 齐多美辛 鸭脚树叶碱 鸭脚木碱,鸡骨常山碱 鲜麦得新糖 高氯酸1,1’-二(十六烷基)-3,3,3’,3’-四甲基吲哚碳菁 马鲁司特 马来酸阿洛司琼 马来酸替加色罗 顺式-ent-他达拉非 顺式-1,3,4,4a,5,9b-六氢-2H-吡啶并[4,3-b]吲哚-2-甲酸乙酯 顺式-(+-)-3,4-二氢-8-氯-4'-甲基-4-(甲基氨基)-螺(苯并(cd)吲哚-5(1H),2'(5'H)-呋喃)-5'-酮 靛红联二甲酚 靛红磺酸钠 靛红磺酸 靛红乙烯硫代缩酮 靛红-7-甲酸甲酯 靛红-5-磺酸钠 靛红-5-磺酸 靛红-5-硫酸钠盐二水 靛红-5-甲酸甲酯 靛红 靛玉红3'-单肟5-磺酸 靛玉红-3'-单肟 靛玉红 青色素3联己酸染料,钾盐 雷马曲班 雷莫司琼杂质13 雷莫司琼杂质12 雷莫司琼杂质 雷替尼卜定 雄甾-1,4-二烯-3,17-二酮 阿霉素的代谢产物盐酸盐 阿贝卡尔 阿西美辛叔丁基酯 阿西美辛 阿莫曲普坦杂质1 阿莫曲普坦 阿莫曲坦二聚体杂质 阿莫曲坦 阿洛司琼杂质